Verona Pharma plc
VRNA
Classement en actions
#2230
Verona Pharma plc is a biopharmaceutical company currently in its clinical... Verona Pharma plc is a biopharmaceutical company currently in its clinical development phase, focusing on the research, development, and eventual market launch of new therapies for respiratory illnesses where current treatments are inadequate. Its primary experimental medication is ensifentrine, an inhaled compound designed to simultaneously block both phosphodiesterase (PDE) 3 and PDE4 enzymes. This unique mechanism allows it to function both as a bronchodilator, helping to open the airways, and as an anti-inflammatory agent within a single drug. Ensifentrine is presently undergoing advanced (Phase 3) clinical trials to evaluate its effectiveness in treating chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis. To provide versatile administration options, the company is developing ensifentrine in three distinct formulations: a nebulizer solution, a dry powder inhaler (DPI), and a pressurized metered-dose inhaler (pMDI). Verona Pharma plc was established in 2005 and conducts its operations from its headquarters in London, United Kingdom.
Prix de l'action
$106.91
Dernière synchronisation: 2025-10-07
Capitalisation boursière
$9.09B
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
GB
Échange Verona Pharma plc (VRNA)
Catégorie
Healthcare
Historique des divisions d’actions pour Verona Pharma plc (VRNA)
L’action Verona Pharma plc (symbole : VRNA) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Oct 21, 2026.
Une action VRNA achetée avant le Oct 21, 2026 équivaudrait aujourd’hui à 0 actions VRNA.
La division la plus récente a eu lieu le Oct 21, 2026.
Une action VRNA achetée avant le Oct 21, 2026 équivaudrait aujourd’hui à 0 actions VRNA.
Liste des divisions d’actions
| Année | Division | Multiplicateur | Multiplicateur cumulatif |
|---|---|---|---|
| Pas assez de données pour les dates fournies. | |||
Divisions d’actions d’entreprises similaires ou concurrentes
| Entreprise | Nombre de divisions d’actions | Multiplicateur cumulatif | Pays |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
